Improving patient access to hepatitis C antiviral medicines in Switzerland: Understanding the financial risks for community pharmacies

Jérôme Berger*, Aline Bourdin, Fatima Pires, Claudine Backes, Clémence Perraudin, Olivier Bugnon

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Improving patient access to hepatitis C antiviral medicines in Switzerland: Understanding the financial risks for community pharmacies'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science